This is a non-core endpoint: only basic statistics are computed.
Other neonatal haemorrhages
P16_OTH_NEONTAL_HAEMORRHAGES
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
13 |
4. Check minimum number of eventsNone |
13 |
5. Include endpointsNone |
13 |
6. Filter based on genotype QC (FinnGen only) |
13 |
Control definitions (FinnGen only)
- Control exclude
- P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P[5-6]
- Name in latin
- Aliae haemorrhagiae fetales et neonatales
Similar endpoints
↥List of similar endpoints to
Other neonatal haemorrhages
based on the number of shared cases.
Similar with more cases:
- Haemorrhagic and haematological disorders of fetus and newborn
- Certain conditions originating in the perinatal period
- Dental operations
- Factors influencing health status and contact with health services
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
Not enough data for upset plot.
Not enough data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1262 | 601 | 661 |
| Only index persons | 530 | 237 | 293 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | - | 0.06 | 0.07 |
| Only index persons | 0.06 | 0.05 | 0.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13 | 10 | - |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | - |
| Median age at first event (years) | 0.07 | 0.07 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012095) Magnesium [Moles/volume] in Serum or Plasma
5
9
8.17
2.45
7.8
28.9
mmol/l
0.8
0.8
—
5
9
(3020779) Urea [Moles/volume] in Serum or Plasma
5
11
6.61
2.16
7.0
26.7
mmol/l
4.7
4.3
—
5
11
(3018677) aPTT in Platelet poor plasma by Coagulation assay
5
15
4.71
1.70
3.4
15.7
s
30.6
33.4
—
5
15
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
25
3.56
1.45
3.3
13.5
mmol/l
24.7
25.6
—
6
25
(3026008) Bacteria identified in Urine by Culture
7
36
3.02
1.21
3.0
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
6
29
2.96
1.07
11.3
10.2
g/l
41.0
37.6
—
6
29
(3044889) 12 lead EKG panel
8
47
2.80
0.88
3.6
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
13
110
+∞
0.67
18.4
10.5
mg/l
32.4
20.3
—
8
78
(40761511) CBC panel - Blood by Automated count
13
108
+∞
0.66
12.8
6.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
7
47
2.05
0.62
1.4
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
5
33
1.83
0.48
7.0
5.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
5
34
1.76
0.47
7.0
5.4
e6/l
0.0
0.1
—
5
27
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5
34
1.76
0.47
3.0
5.6
—
—
—
0
0
(3015736) pH of Urine
6
39
1.99
0.46
2.2
4.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
6
40
1.92
0.46
6.3
6.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
0
15
0.00
0.44
0.0
7.7
—
918.3
—
0
8
(3050129) First trimester maternal screen panel - Serum or Plasma
0
14
0.00
0.44
0.0
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
13
113
+∞
0.44
4.8
3.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
18
0.00
0.43
0.0
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
5
37
1.57
0.28
7.0
5.6
e6/l
10.9
13.5
—
5
30
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6
45
1.61
0.26
5.2
4.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
7
81
0.71
0.25
3.9
4.1
mm/h
5.9
6.2
—
7
74
(3037467) Urinalysis macro (dipstick) panel - Urine
8
67
1.50
0.24
6.3
5.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.3
—
252.1
—
0
10
(3021960) Folate [Moles/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.2
—
19.0
—
0
10
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
12
0.00
0.22
0.0
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
0
12
0.00
0.22
0.0
7.5
—
230.8
—
0
12
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.22
0.0
1.4
—
—
—
0
0
(3000492) Spirometry study
0
12
0.00
0.22
0.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
12
0.00
0.22
0.0
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
0
12
0.00
0.22
0.0
3.5
—
1.1
—
0
12
(3005719) IgG [Mass/volume] in Serum or Plasma
0
12
0.00
0.22
0.0
5.1
—
9.8
—
0
12
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.22
0.0
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
0
13
0.00
0.22
0.0
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.22
0.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
5
41
1.35
0.12
7.8
7.0
e6/l
27.9
29.6
—
5
31
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
59
0.75
0.11
3.0
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
6
0.00
0.00
0.0
8.3
—
46.7
—
0
6
(3045414) Leukocytes [Presence] in Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
0
6
0.00
0.00
0.0
2.8
—
68.7
—
0
6
(3010813) Leukocytes [#/volume] in Blood
13
124
+∞
0.00
25.2
15.9
e9/l
7.0
6.5
0.28
13
119
(3006245) CD3-CD19+ cells/100 cells in Blood
0
6
0.00
0.00
0.0
1.5
—
9.2
—
0
6
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
6
0.00
0.00
0.0
5.0
—
0.0
—
0
6
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
15.8
—
0
6
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
6
58
1.06
0.00
1.3
1.8
—
0.6
—
0
13
(4010399)
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
5
0.00
0.00
0.0
1.4
—
27.6
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44790049)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
3.0
—
0
5
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
0.3
—
0
7
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(44790047)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
3.4
—
2.0
—
0
5
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
7
0.00
0.00
0.0
13.1
—
126.4
—
0
7
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
7
0.00
0.00
0.0
13.6
—
1.1
—
0
7
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
9.0
—
22.5
—
0
5
(44790048)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
1.5
—
0
7
(44806118)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
2.4
—
0
5
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_OTH_NEONTAL_HAEMORRHAGES and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_OTH_NEONTAL_HAEMORRHAGES.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_OTH_NEONTAL_HAEMORRHAGES – Other neonatal haemorrhages
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data